300 patients, advocates and researchers talk science, health disparities and filling in crucial data gaps at 'mets' conference
Sept. 26, 2017
| By Diane Mapes / Fred Hutch News Service
More than 300 metastatic breast cancer patients, researchers, advocates and caregivers gathered in Seattle over the weekend to discuss promising new therapies, patient-researcher partnerships, big data, advocacy, and, yes, cures.
Fred Hutchinson Cancer Research Center has become the first U.S. cancer center to join a growing coalition pledging to advance diversity and inclusion in the workplace. On Aug. 25, Fred Hutch President and Director Dr. Gary Gilliland joined more than 270 CEOs nationwide who have taken the pledge as part of the CEO Action for Diversity & Inclusion.™
High response rates to experimental immunotherapy in patients with treatment-resistant chronic lymphocytic leukemia
July 17, 2017
| By Susan Keown / Fred Hutch News Service
Most patients with recurrent chronic lymphocytic leukemia who were enrolled in a small, early- phase trial saw their advanced tumors shrink or even disappear after an infusion of genetically engineered immune cells. Dr. Cameron Turtle, one of the study’s leaders, presented the results on Saturday at the 2016 annual meeting of the American Society of Hematology in San Diego.
New research writes latest chapter in one drug's story
June 27, 2017
| by Susan Keown / Fred Hutch News Service
The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.